Last reviewed · How we verify

NCT06811311: EEG-HypnoGAD

EEG Study on Neurophysiological and Psychological Effects of Ericksonian Hypnotherapy in Generalized Anxiety Disorder

Recruiting now NA Last updated 20 February 2025
What this trial tests

NA trial testing Ericksonian Hypnotherapy in Generalized Anxiety Disorder (GAD) in 60 participants. Currently enrolling.

Timeline
1 February 2025
Primary endpoint
15 July 2025
1 September 2025

Quick facts

Lead sponsorUskudar University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date1 February 2025
Primary completion15 July 2025
Estimated completion1 September 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Uskudar University

Who can join

Adults 18 to 65, any sex, with Generalized Anxiety Disorder (GAD) or Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study examines the neurophysiological and psychological effects of Ericksonian hypnotherapy in individuals diagnosed with Generalized Anxiety Disorder (GAD). Using electroencephalography (EEG), the study aims to assess changes in brain activity and anxiety symptoms before and after treatment. A total of 60 participants will be recruited from both governmental and private psychiatric clinics in Istanbul. Participants will be randomly assigned to either the intervention group (receiving 12 Ericksonian hypnotherapy sessions over 12 weeks) or the control group (receiving no intervention). The primary outcome measures include changes in EEG patterns, specifically alpha, theta, and frontal asymmetry indices, and changes in anxiety severity, measured by the Beck Anxiety Inventory (BAI), Generalized Anxiety Disorder-7 (GAD-7), and State-Trait Anxiety Inventory (STAI). Secondary measures include emotional regulation (DERS) and quality of life (WHOQOL-BREF). This study aims to provide scientific evidence on the effectiveness of Ericksonian hypnotherapy as a complementary treatment for GAD and its impact on brain function and emotional well-being.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ericksonian Hypnotherapy

Trials testing the same drug.

Other recruiting trials for Generalized Anxiety Disorder (GAD)

Currently open trials in the same condition.

Other Uskudar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06811311.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing